NEXT STEPS FOR PROMISING TECHNOLOGIES
Acies Bio can also be actively engaged in proprietary early stage R&D programs, carried out in its own facilities or in collaboration with R&D partners from academic and business sectors. When these projects lead to generation of new IP, capable of protecting broad technological areas with patent applications, they may become a basis for a new company with its own mission and focus. Acies Bio is actively pursuing commercialization of such technologies by licensing agreements or establishing spin-off / joint-venture companies with market-access partners.
In such joint-venture companies, Acies Bio’s main inputs are the background knowledge and know how, any relevant IP as well as subsequent research and development. Acies Bio also has expertise in design of manufacturing facilities and technology transfer, while the market access partner is expected to manage actual manufacturing, distribution and sales.